Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Wearable Medical Device Market Worth USD13 Billion in 2016

By HospiMedica International staff writers
Posted on 03 Nov 2016
The global wearable medical device market is valued at just over USD13.2 billion for 2016, as healthcare remains among the fastest growing segments for wearables due to the overwhelming need to monitor diseases and aging populations.

These are the latest findings of Kalorama Information, (New York, NY, USA), an independent medical market research firm.

The wearable medical device market includes products in four segments, namely Lifestyle and Fitness, Diagnostics and Monitoring, Therapeutic, and Injury Prevention and Rehabilitation. More...
The Lifestyle and Fitness segment, which is the most advanced category of the wearable medical devices market, includes fitness trackers, activity trackers, and sports trackers. The Diagnostics and Monitoring segment includes non-invasive devices that provide valuable health information, such as glucose monitoring; cardiovascular monitoring and event recording; pregnancy, obstetrics, fetal and infant monitoring; neurological monitoring, like electroencephalogram (EEG) tests; and sleep monitoring devices.

The Therapeutic segment includes wearable systems that monitor disease states and track health activity, store data and deliver feedback therapy, including respiratory therapy, insulin management, pain management devices. Lastly, the Injury Prevention and Rehabilitation segment includes non-invasive wearable devices that provide valuable health information, including body motion, wearable sensing garment, and fall detection among others.

Wearable devices now focus on various bodily measurements such as heart rate, breathing, blood pressure and many others. New wireless and Bluetooth technologies, improved infrastructure, and patient familiarity with wireless devices are together driving sales and use of new technologies in wearable medical devices. Some advances in wearable medical devices that are making it easier for patients and physicians to incorporate wearable medical devices into their daily routine include new miniaturized sensors; peripherals; real-time measurements and interactions, wireless communication, sort-and-analyze features, portability and data transfer capabilities.

A large number of companies offer products with some form of wearable advanced features, such as wireless/remote health monitoring technologies, patient data processing applications and equipment, and applications and equipment that transfer patient monitoring data to EMRs. Some of the players providing leading products and interesting new technologies in the wearable medical device space include Philips Healthcare, Dexcom, Medtronic, Bioness, Fitbit, and Apple.

Kalorama Information >>> www.kaloramainformation.com

Related Links:
Kalorama Information


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.